1. K.J. Watkins, Fighting the clock, Chem. Eng. News, Jan. 28, 27–34 (2002).
2. C.A. Shillingford and C.W. Vose, Effective decision making: progressing compounds through clinical development, Drug Disc. Today, 6(18), 941–946 (2001).
3. A. Barrett, Commentary: How drugmakers should handle a cautious FDA, Bus. Week, May 20 (2002).
4. J. Kuhlman, Drug research: From idea to the product, Int. J. Clin. Pharm. Ther. 35, 541–552 (1997).
5. A.V. Boddy and S.M. Yule, Metabolism and pharmacokinetics of oxazaphosphorines, Drug Disp. 38(4), 291–304 (2000).